Teikyo University Hospital, Mizonokuchi
- Research works
- 28 ▲ 3035% vs 2013–17
- Citations
- 268 9.7 per fractional work
- Top-10% rate
- 4.2% record average 16.5%
- Open access
- 47% world 28%
Not ranked overall: Teikyo University Hospital, Mizonokuchi is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.5×. Every wedge is a field page.
Which keywords describe research at Teikyo University Hospital, Mizonokuchi?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Surgical Management, Gastric Cancer, Neoadjuvant Therapy, Epidemiology, Survival Analysis and Endoscopic Resection.
- Radiotherapy
- Immunotherapy
- Adjuvant Chemotherapy
- Lymph Node Dissection
- Preoperative Chemoradiotherapy
- Inflammation
- Quality of Life
- Endoscopic Resection
- Neoadjuvant Therapy
- Surgical Management
- Chemotherapy
- Epidemiology
- Clinical Practice Guidelines
- Gastric Cancer
- Adjuvant Therapy
- Molecular Characterization
- Survival Analysis
- Neoadjuvant Chemotherapy
- Cholangiocarcinoma
- Metastatic Gastric Cancer
- Hearing Loss
- Laparoscopic Surgery
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 22 words, with their numbers
- Epidemiology3▲ 2.5×18 topics
- Chemotherapy2▲ 12×9 topics
- Clinical Practice Guidelines2▲ 15×5 topics
- Surgical Management2▲ 17×9 topics
- Gastric Cancer2▲ 50×3 topics
- Neoadjuvant Therapy2▲ 26×4 topics
- Adjuvant Therapy2▲ 47×2 topics
- Endoscopic Resection2▲ 58×2 topics
- Molecular Characterization2▲ 29×3 topics
- Quality of Life2▲ 4.1×11 topics
- Survival Analysis2▲ 20×4 topics
- Inflammation1▲ 1.98×7 topics
- Neoadjuvant Chemotherapy1▲ 52×2 topics
- Preoperative Chemoradiotherapy1▲ 65×2 topics
- Cholangiocarcinoma1▲ 56×2 topics
- Lymph Node Dissection1▲ 74×1 topic
- Metastatic Gastric Cancer1▲ 74×1 topic
- Adjuvant Chemotherapy1▲ 57×2 topics
- Hearing Loss1▲ 26×3 topics
- Immunotherapy1▲ 5.6×7 topics
- Laparoscopic Surgery1▲ 34×2 topics
- Radiotherapy1▲ 9.9×4 topics
Which research topics does Teikyo University Hospital, Mizonokuchi publish most on?
By volume in 2022–2025: Gastric Cancer Management and Outcomes, Ear Surgery and Otitis Media, Pharmacy and Medical Practices and Colorectal Cancer Surgical Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 1 works
- 2 Ear Surgery and Otitis Media Otorhinolaryngology 1 works
- 3 Pharmacy and Medical Practices Pharmacology 0 works
- 4 Colorectal Cancer Surgical Treatments Oncology 0 works
- 5 Ear and Head Tumors Oncology 0 works
- 6 Bariatric Surgery and Outcomes Surgery 0 works
- 7 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 8 Salivary Gland Tumors Diagnosis and Treatment Surgery 0 works
- 9 Esophageal Cancer Research and Treatment Surgery 0 works
- 10 Intraperitoneal and Appendiceal Malignancies Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Teikyo University Hospital, Mizonokuchi's research output changed?
Output in 2018–2022 was 3035% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kawasaki
- Toshiba Nanoanalysis Corporation
- Mitsubishi Fuso Truck and Bus (Japan)
- Environmental Restoration and Conservation Agency
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.